Identification of Infants at Risk for Type 1 Diabetes
Study summary
The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.
Eligibility
Sex
ALL
Min age
1 Day
Max age
6 Weeks
Healthy volunteers
Accepted
Inclusion Criteria:
* Age: up to age 6 weeks
* provided written informed consent by custodial parent
Exclusion Criteria:
\-
Primary outcome measure(s)
greater than 10% risk for multiple beta-cell autoantibodies/type 1 diabetes — one-time testing before age 6 weeks increased risk will be identified by risk scores derived from SNPs
Trial sites (1)
Facility
City
Region
Status
Institut für Diabetesforschung, Helmholtz Zentrum München
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.